374 related articles for article (PubMed ID: 15933632)
1. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
[TBL] [Abstract][Full Text] [Related]
2. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC
Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
[TBL] [Abstract][Full Text] [Related]
4. Peritonitis in childhood: clinical relevance of cytokines in the peritoneal exudate.
Haecker FM; Fasler-Kan E; Manasse C; Fowler B; Hertel R; von Schweinitz D
Eur J Pediatr Surg; 2006 Apr; 16(2):94-9. PubMed ID: 16685614
[TBL] [Abstract][Full Text] [Related]
5. Induction of endotoxin tolerance with monophosphoryl lipid A in peritonitis: importance of localized therapy.
Astiz ME; Saha DC; Carpati CM; Rackow EC
J Lab Clin Med; 1994 Jan; 123(1):89-93. PubMed ID: 8288966
[TBL] [Abstract][Full Text] [Related]
6. Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis.
Lenz AM; Franklin GA; Fairweather M; McClintock ML; Jala VR; Peyton JC; Gardner SA; Cheadle WG
Cytokine; 2007 Dec; 40(3):207-15. PubMed ID: 18053738
[TBL] [Abstract][Full Text] [Related]
7. Early effects of laparotomy and laparoscopy on bacterial behavior and proinflammatory cytokines on bacterial peritonitis in rats I: Escherichia coli.
Didem B; Hüseyin B; Osman Y; Yasemin B; Necati G; Canan T
J Pediatr Surg; 2008 Aug; 43(8):1494-501. PubMed ID: 18675641
[TBL] [Abstract][Full Text] [Related]
8. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice.
Brüggemann LW; Schoenmakers SH; Groot AP; Reitsma PH; Spek CA
Crit Care Med; 2006 Aug; 34(8):2201-6. PubMed ID: 16775574
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis.
Renckens R; Roelofs JJ; Florquin S; van der Poll T
J Infect Dis; 2006 Feb; 193(4):522-30. PubMed ID: 16425131
[TBL] [Abstract][Full Text] [Related]
11. Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis.
Tsukada K; Katoh H; Shiojima M; Takenoshita S; Nagamachi Y
APMIS; 1993 Feb; 101(2):97-100. PubMed ID: 8489768
[TBL] [Abstract][Full Text] [Related]
12. Genetic background determines susceptibility during murine septic peritonitis.
Godshall CJ; Scott MJ; Peyton JC; Gardner SA; Cheadle WG
J Surg Res; 2002 Jan; 102(1):45-9. PubMed ID: 11792151
[TBL] [Abstract][Full Text] [Related]
13. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE
J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
[TBL] [Abstract][Full Text] [Related]
15. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
Lally KP; Cruz E; Xue H
J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
[TBL] [Abstract][Full Text] [Related]
16. Bile increases lipopolysaccharide release in experimental E. coli peritonitis.
Andersson R; Sonesson A; Larsson L; Schalén C; Tranberg KG
Eur J Surg; 1991 Feb; 157(2):117-20. PubMed ID: 1676304
[TBL] [Abstract][Full Text] [Related]
17. Liver lipid peroxidation in experimental Escherichia coli peritonitis: the role of myeloperoxidase and nitric oxide inhibition.
Demir M; Sert S; Kaleli I; Demir S; Cevahir N; Yildirim U; Sahin B
Med Sci Monit; 2007 Oct; 13(10):BR225-9. PubMed ID: 17901846
[TBL] [Abstract][Full Text] [Related]
18. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance.
Sewnath ME; Olszyna DP; Birjmohun R; ten Kate FJ; Gouma DJ; van Der Poll T
J Immunol; 2001 May; 166(10):6323-31. PubMed ID: 11342656
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of alpha7 cholinergic receptors facilitates bacterial clearance in Escherichia coli peritonitis.
Giebelen IA; Le Moine A; van den Pangaart PS; Sadis C; Goldman M; Florquin S; van der Poll T
J Infect Dis; 2008 Sep; 198(5):750-7. PubMed ID: 18627272
[TBL] [Abstract][Full Text] [Related]
20. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.
Tan XX; Actor JK; Chen Y
Antimicrob Agents Chemother; 2005 Aug; 49(8):3203-7. PubMed ID: 16048926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
